Infections in the Immunocompromised Host : Laboratory Diagnosis and Treatment (Advances in Experimental Medicine and Biology)

個数:

Infections in the Immunocompromised Host : Laboratory Diagnosis and Treatment (Advances in Experimental Medicine and Biology)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 208 p.
  • 言語 ENG
  • 商品コード 9781468412611
  • DDC分類 616

Full Description

The subject matter of this volume, the basis for which was a conference held in Philadelphia which focused on the subject of infections, including their diagnosis and treatment, in immunocompromised individuals. The material is of particular importance today when placed against the background of the rapid spread of acquired immunodeficiency syndrome (AIDS). The first section dealt with the general subject of the immunocompromised host. Here, reviewed in detail, were the epidemiological and clinical aspects of opportunistic infections in patients with defective immune responses. It is widely acknowledged that infections are a major complication of the neoplastic process. Cancer-bearing patients are more prone to certain kinds of infectious and cancer chemotherapy almost always increases susceptibility to such infections. Depending upon the basic disease process of the cancer, a specific array of infectious diseases can be predicted. Patients altered in thymus-derived lymphocyte populations or mononuclear phagocyte capabilities resulting in defects in cell mediated immunity or delayed hypersensitivity become highly susceptible to certain groups of organisms, whereas, profoundly neutropenic patients usually become infected with different organisms. The types of infections noted are relatively predictable for the type of immune defect, with some variations according to epidemiological factors. Major advances have been made in the early diagnosis and treatment of infectious complications with increasingly effective antimicrobial agents and increasing knowledge of their use. The application of so-called preventive procedures has had limited value to date, including immunotherapy, which appears to hold much promise.

Contents

The Immunocompromised Host — An Overview.- Epidemiologic and Clinical Aspects of Opportunistic Infections.- Immunomodulating Effects of Microorganisms and Their Products on the Immune Response Mechanisms.- The Diagnosis and Definition of the Acquired Immunodeficiency Syndrome.- Bacterial and Viral Infections in the Compromised Host.- M.I.D.A.S. — An On-Line Microbiology Information System.- Opportunistic Mycobacterial Infections.- Laboratory Diagnosis of Herpes Viruses in the Immunocompromised Host.- Herpesvirus Infections in the Immunocompromised Host: Diagnosis and Management.- Fungal and Parasitic Infections in the Immunocompromised Host — An Overview.- Fungal Infections in the Compromised Host.- Susceptibility Testing of Medically Important Fungi.- Cryptosporidium — Biology and Diagnosis.- Pneumocystis Carinii Pneumonia.- Immunotherapy.- Liposome Targeting to Macrophages: Opportunities for Treatment of Infectious Diseases.- Biologicals and Other Biological Response Modifiers: Preclinical and Clinical Assessment in Cancer Treatment.

最近チェックした商品